Losartan improves resistance artery lesions and prevents CTGF and TGF-beta production in mild hypertensive patients (Q46947467)

26 December 2017

title

Losartan improves resistance artery lesions and prevents CTGF and TGF-beta production in mild hypertensive patients (English)

1 reference

26 December 2017

1 reference

Gómez-Garre D

1

1 reference

26 December 2017

Martín-Ventura JL

2

1 reference

26 December 2017

Granados R

3

1 reference

26 December 2017

Sancho T

4

1 reference

26 December 2017

Torres R

5

1 reference

26 December 2017

Ruano M

6

1 reference

26 December 2017

García-Puig J

7

1 reference

26 December 2017

Egido J

8

1 reference

26 December 2017

language of work or name

English

0 references

publication date

1 April 2006

1 reference

26 December 2017

published in

Kidney International

1 reference

26 December 2017

volume

69

1 reference

26 December 2017

issue

7

1 reference

26 December 2017

page(s)

1237-1244

1 reference

26 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.ki.5000034

exact match

0 references

cites work

Pathophysiology of hypertensive renal damage: implications for therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000034

7 January 2021

Structure and mechanical properties of resistance arteries in hypertension: role of adhesion molecules and extracellular matrix determinants

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000034

7 January 2021

Mechanics and composition of human subcutaneous resistance arteries in essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000034

7 January 2021

Enalapril does not prevent renal arterial hypertrophy in spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000034

7 January 2021

Small artery remodeling is the most prevalent (earliest?) form of target organ damage in mild essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000034

7 January 2021

Prognostic significance of small-artery structure in hypertension.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000034

7 January 2021

Effects of low and high doses of fosinopril on the structure and function of resistance arteries

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000034

7 January 2021

Effects of losartan and enalapril on small artery structure in hypertensive rats.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000034

7 January 2021

Effects of a beta-blocker or a converting enzyme inhibitor on resistance arteries in essential hypertension.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000034

7 January 2021

Effect of antihypertensive treatment on small arteries of patients with previously untreated essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000034

7 January 2021

Effect of crossing over hypertensive patients from a beta-blocker to an angiotensin receptor antagonist on resistance artery structure and on endothelial function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000034

7 January 2021

Effect of AT1 angiotensin-receptor blockade on structure and function of small arteries in SHR

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000034

7 January 2021

Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin receptor antagonist losartan

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000034

7 January 2021

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000034

7 January 2021

Molecular mechanisms of angiotensin II-induced vascular injury.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000034

7 January 2021

Effects and interactions of endothelin-1 and angiotensin II on matrix protein expression and synthesis and mesangial cell growth

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000034

7 January 2021

Connective tissue growth factor is a mediator of angiotensin II-induced fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000034

7 January 2021

Gene regulation of connective tissue growth factor: new targets for antifibrotic therapy?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000034

7 January 2021

The effects of amlodipine compared to losartan in patients with mild to moderately severe hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000034

7 January 2021

Effect of angiotensin II receptor blocker on plasma levels of TGF-beta 1 and interstitial fibrosis in hypertensive kidney transplant patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000034

7 January 2021

Arterial structural changes in hypertension: a consideration of methodology, terminology and functional consequence

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000034

7 January 2021

How to assess vascular remodelling in small and medium-sized muscular arteries in humans

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000034

7 January 2021

Effect of amlodipine compared to atenolol on small arteries of previously untreated essential hypertensive patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000034

7 January 2021

Effect of antihypertensive treatment on cardiac and subcutaneous artery structure: a comparison between calcium channel blocker and thiazide-based regimens

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000034

7 January 2021

Progressive improvement in the structure of resistance arteries of hypertensive patients after 2 years of treatment with an angiotensin I-converting enzyme inhibitor. Comparison with effects of a beta-blocker.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000034

7 January 2021

Collagen I and III mRNA gene expression and cell growth potential of skin fibroblasts in patients with essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000034

7 January 2021

Tight blood pressure control decreases apoptosis during renal damage

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000034

7 January 2021

Characteristics and expression of transforming growth factor-beta receptor subtypes on vascular smooth muscle cells from spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000034

7 January 2021

Angiotensin II activates collagen type I gene in the renal vasculature of transgenic mice during inhibition of nitric oxide synthesis: evidence for an endothelin-mediated mechanism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000034

7 January 2021

Regression of renal vascular and glomerular fibrosis: role of angiotensin II receptor antagonism and matrix metalloproteinases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000034

7 January 2021

Different effects of calcium channel blockers on matrix metalloproteinase-2 expression in cultured rat cardiac fibroblasts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000034

7 January 2021

Vascular matrix metalloproteinase-2 cleaves big endothelin-1 yielding a novel vasoconstrictor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000034

7 January 2021

Structural changes in small resistance arteries and left ventricular geometry in patients with primary and secondary hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000034

7 January 2021

Identifiers

DOI

10.1038/SJ.KI.5000034

1 reference

26 December 2017

PubMed ID

16482098

1 reference

26 December 2017